Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2015, Article ID 618658, 7 pages
http://dx.doi.org/10.1155/2015/618658
Research Article

Modelling the Effect of SPION Size in a Stent Assisted Magnetic Drug Targeting System with Interparticle Interactions

1Department of Biology and Biological Engineering, Chalmers University of Technology, 412 96 Gothenburg, Sweden
2Materials Characterisation & Processing Group, Waterford Institute of Technology, Waterford, Ireland

Received 28 September 2014; Accepted 1 February 2015

Academic Editor: Pradip Paik

Copyright © 2015 Adil Mardinoglu and P. J. Cregg. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Hanahan and R. A. Weinberg, “Hallmarks of cancer: the next generation,” Cell, vol. 144, no. 5, pp. 646–674, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. M. G. Vander Heiden, “Targeting cancer metabolism: a therapeutic window opens,” Nature Reviews Drug Discovery, vol. 10, no. 9, pp. 671–684, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. D. A. Tennant, R. V. Durán, and E. Gottlieb, “Targeting metabolic transformation for cancer therapy,” Nature Reviews Cancer, vol. 10, no. 4, pp. 267–277, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. S. H. Kaufmann and W. C. Earnshaw, “Induction of apoptosis by cancer chemotherapy,” Experimental Cell Research, vol. 256, no. 1, pp. 42–49, 2000. View at Publisher · View at Google Scholar · View at Scopus
  5. H. Kempe and M. Kempe, “The use of magnetite nanoparticles for implant-assisted magnetic drug targeting in thrombolytic therapy,” Biomaterials, vol. 31, pp. 9499–9510, 2010. View at Google Scholar
  6. A. S. Lübbe, C. Alexiou, and C. Bergemann, “Clinical applications of magnetic drug targeting,” Journal of Surgical Research, vol. 95, no. 2, pp. 200–206, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Riegler, J. A. Wells, P. G. Kyrtatos, A. N. Price, Q. A. Pankhurst, and M. F. Lythgoe, “Targeted magnetic delivery and tracking of cells using a magnetic resonance imaging system,” Biomaterials, vol. 31, no. 20, pp. 5366–5371, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. B. Shapiro, S. Kulkarni, A. Nacev, S. Muro, P. Y. Stepanov, and I. N. Weinberg, “Open challenges in magnetic drug targeting,” Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, 2014. View at Publisher · View at Google Scholar
  9. A. S. Lübbe, C. Bergemann, H. Riess et al., “Clinical experiences with magnetic drug targeting: a phase I study with 4'-epidoxorubicin in 14 patients with advanced solid tumors,” Cancer Research, vol. 56, no. 20, pp. 4686–4693, 1996. View at Google Scholar · View at Scopus
  10. G. Iacob, O. Rotariu, N. J. C. Strachan, and U. O. Häfeli, “Magnetizable needles and wires—modeling an efficient way to target magnetic microspheres in vivo,” Biorheology, vol. 41, no. 5, pp. 599–612, 2004. View at Google Scholar · View at Scopus
  11. A. Nacev, I. N. Weinberg, P. Y. Stepanov et al., “Dynamic inversion enables external magnets to concentrate ferromagnetic rods to a central target,” Nano Letters, vol. 15, no. 1, pp. 359–364, 2015. View at Publisher · View at Google Scholar
  12. B. B. Yellen, Z. G. Forbes, D. S. Halverson et al., “Targeted drug delivery to magnetic implants for therapeutic applications,” Journal of Magnetism and Magnetic Materials, vol. 293, no. 1, pp. 647–654, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. A. J. Rosengart, M. D. Kaminski, H. T. Chen, P. L. Caviness, A. D. Ebner, and J. A. Ritter, “Magnetizable implants and functionalized magnetic carriers: a novel approach for noninvasive yet targeted drug delivery,” Journal of Magnetism and Magnetic Materials, vol. 293, no. 1, pp. 633–638, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. J. A. Ritter, A. D. Ebner, K. D. Daniel, and K. L. Stewart, “Application of high gradient magnetic separation principles to magnetic drug targeting,” Journal of Magnetism and Magnetic Materials, vol. 280, no. 2-3, pp. 184–201, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Mardinoglu, Inclusion of interactions in mathematical modelling of implant assisted magnetic drug targeting [Ph.D. thesis], School of Engineering, Waterford Institute of Technology, Waterford, Ireland, 2009.
  16. P. J. Cregg, K. Murphy, and A. Mardinoglu, “Calculation of nanoparticle capture efficiency in magnetic drug targeting,” Journal of Magnetism and Magnetic Materials, vol. 320, no. 23, pp. 3272–3275, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. P. J. Cregg, K. Murphy, and A. Mardinoglu, “Inclusion of magnetic dipole-dipole and hydrodynamic interactions in implant-assisted magnetic drug targeting,” Journal of Magnetism and Magnetic Materials, vol. 321, no. 23, pp. 3893–3898, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. P. J. Cregg, K. Murphy, A. Mardinoglu, and A. Prina-Mello, “Many particle magnetic dipole-dipole and hydrodynamic interactions in magnetizable stent assisted magnetic drug targeting,” Journal of Magnetism and Magnetic Materials, vol. 322, no. 15, pp. 2087–2094, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. P. J. Cregg, K. Murphy, and A. Mardinoglu, “Inclusion of interactions in mathematical modelling of implant assisted magnetic drug targeting,” Applied Mathematical Modelling, vol. 36, no. 1, pp. 1–34, 2012. View at Publisher · View at Google Scholar · View at MathSciNet · View at Scopus
  20. H. Chen, A. D. Ebner, M. D. Kaminski, A. J. Rosengart, and J. A. Ritter, “Analysis of magnetic drug carrier particle capture by a magnetizable intravascular stent—2: parametric study with multi-wire two-dimensional model,” Journal of Magnetism and Magnetic Materials, vol. 293, no. 1, pp. 616–632, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. M. O. Avilés, A. D. Ebner, and J. A. Ritter, “Ferromagnetic seeding for the magnetic targeting of drugs and radiation in capillary beds,” Journal of Magnetism and Magnetic Materials, vol. 310, no. 1, pp. 131–144, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. M. O. Avilés, A. D. Ebner, and J. A. Ritter, “Implant assisted-magnetic drug targeting: comparison of in vitro experiments with theory,” Journal of Magnetism and Magnetic Materials, vol. 320, no. 21, pp. 2704–2713, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. J. O. Mangual, M. O. Avilés, A. D. Ebner, and J. A. Ritter, “In vitro study of magnetic nanoparticles as the implant for implant assisted magnetic drug targeting,” Journal of Magnetism and Magnetic Materials, vol. 323, no. 14, pp. 1903–1908, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Mardinoglu, P. J. Cregg, K. Murphy, M. Curtin, and A. Prina-Mello, “Theoretical modelling of physiologically stretched vessel in magnetisable stent assisted magnetic drug targeting application,” Journal of Magnetism and Magnetic Materials, vol. 323, no. 3-4, pp. 324–329, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. C. Sheridan, “Proof of concept for next-generation nanoparticle drugs in humans,” Nature Biotechnology, vol. 30, no. 6, pp. 471–473, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. J.-H. Lee, B. Schneider, E. K. Jordan, W. Liu, and J. A. Frank, “Synthesis of complexable fluorescent superparamagnetic iron oxide nanoparticles (FL SPIONs) and cell labeling for clinical application,” Advanced Materials, vol. 20, no. 13, pp. 2512–2516, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. I. J. M. de Vries, W. J. Lesterhuis, J. O. Barentsz et al., “Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy,” Nature Biotechnology, vol. 23, no. 11, pp. 1407–1413, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. D. Caruntu, G. Caruntu, and C. J. O'Connor, “Magnetic properties of variable-sized Fe3O4 nanoparticles synthesized from non-aqueous homogeneous solutions of polyols,” Journal of Physics D: Applied Physics, vol. 40, no. 19, pp. 5801–5809, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. H. Jasak, “OpenFOAM: open source CFD in research and industry,” International Journal of Naval Architecture and Ocean Engineering, vol. 1, no. 2, pp. 89–94, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Mardinoglu, R. Agren, C. Kampf et al., “Integration of clinical data with a genome-scale metabolic model of the human Adipocyte,” Molecular Systems Biology, vol. 9, article 649, 2013. View at Google Scholar · View at Scopus
  31. A. Mardinoglu, R. Agren, C. Kampf, A. Asplund, M. Uhlen, and J. Nielsen, “Genome-scale metabolic modelling of hepatocytes reveals serine deficiency in patients with non-alcoholic fatty liver disease,” Nature Communications, vol. 5, article 3083, 2014. View at Publisher · View at Google Scholar
  32. A. Mardinoglu, C. Kampf, A. Asplund et al., “Defining the human adipose tissue proteome to reveal metabolic alterations in obesity,” Journal of Proteome Research, vol. 13, no. 11, pp. 5106–5119, 2014. View at Publisher · View at Google Scholar
  33. M. Uhlen, L. Fagerberg, B. M. Hallstrom et al., “Tissue-based map of the human proteome,” Science, vol. 347, Article ID 1260419, 2015. View at Publisher · View at Google Scholar
  34. R. Agren, S. Bordel, A. Mardinoglu, N. Pornputtapong, I. Nookaew, and J. Nielsen, “Reconstruction of genome-scale active metabolic networks for 69 human cell types and 16 cancer types using INIT,” PLoS Computational Biology, vol. 8, no. 5, Article ID e1002518, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. R. Agren, A. Mardinoglu, A. Asplund, C. Kampf, M. Uhlen, and J. Nielsen, “Identification of anticancer drugs for hepatocellular carcinoma through personalized genome-scale metabolic modeling,” Molecular Systems Biology, vol. 10, no. 3, article A721, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. P. Ghaffari, A. Mardinoglu, A. Asplund et al., “Identifying anti-growth factors for human cancer cell lines through genome-scale metabolic modeling,” Scientific Reports, vol. 5, article 8183, 2015. View at Publisher · View at Google Scholar
  37. A. Mardinoglu, F. Gatto, and J. Nielsen, “Genome-scale modeling of human metabolism—a systems biology approach,” Biotechnology Journal, vol. 8, no. 9, pp. 985–996, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. A. Mardinoglu and J. Nielsen, “Systems medicine and metabolic modelling,” Journal of Internal Medicine, vol. 271, no. 2, pp. 142–154, 2012. View at Publisher · View at Google Scholar · View at Scopus
  39. M. Uhlen, P. Oksvold, L. Fagerberg et al., “Towards a knowledge-based Human Protein Atlas,” Nature Biotechnology, vol. 28, no. 12, pp. 1248–1250, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. C. Kampf, A. Mardinoglu, L. Fagerberg et al., “The human liver-specific proteome defined by transcriptomics and antibody-based profiling,” The FASEB Journal, vol. 28, no. 7, pp. 2901–2914, 2014. View at Publisher · View at Google Scholar
  41. C. Kampf, A. Mardinoglu, L. Fagerberg et al., “Defining the human gallbladder proteome by transcriptomics and affinity proteomics,” Proteomics, vol. 14, no. 21-22, pp. 2498–2507, 2014. View at Publisher · View at Google Scholar
  42. L. Fagerberg, B. M. Hallstrom, P. Oksvold et al., “Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics,” Molecular and Cellular Proteomics, vol. 13, no. 2, pp. 397–406, 2014. View at Publisher · View at Google Scholar · View at Scopus
  43. D. S. Wishart, C. Knox, A. C. Guo et al., “HMDB: a knowledgebase for the human metabolome,” Nucleic Acids Research, vol. 37, supplement 1, pp. D603–D610, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Mardinoglu and J. Nielsen, “New paradigms for metabolic modeling of human cells,” Current Opinion in Biotechnology, vol. 34, pp. 91–97, 2015. View at Publisher · View at Google Scholar